Business Context and Reporting Period
Company: NL Industries, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2010
Business Overview: NL Industries operates primarily as a holding company. Its main operating subsidiary is CompX International Inc., a manufacturer of security products, precision ball bearing slides, and ergonomic computer support systems. NL also holds a 36% non-controlling interest in Kronos Worldwide, Inc., a global producer of titanium dioxide pigments, accounted for using the equity method.
Key Financial Metrics
| Metric (in thousands) | Q1 2010 | Q1 2009 |
|---|---|---|
| Net Sales | $32,800 | $28,476 |
| Gross Margin | $9,099 | $4,773 |
| Loss from Operations | $(16,882) | $(4,577) |
| Net Loss | $(2,420) | $(11,918) |
| Net Loss Attributable to NL Stockholders | $(2,295) | $(11,843) |
| Diluted Net Loss Per Share | $(0.10) | $(0.24) |
| Cash and Cash Equivalents | $17,980 | $14,627 |
| Total Assets | $459,377 | $402,991 |
| Long-Term Debt | $59,980 | $42,540 |
| Operating Cash Flow | $(5,040) | $(601) |
Material Changes vs. Prior Period
- Improved Net Loss: Net loss attributable to stockholders decreased significantly from $11.8 million in Q1 2009 to $2.3 million in Q1 2010. This improvement was driven by a turnaround in Kronos Worldwide's performance (from a loss to income) and higher insurance recoveries, partially offset by a large litigation settlement charge.
- CompX Performance: CompX net sales increased 15% to $32.8 million due to improving economic conditions. Operating income improved from a loss of $0.9 million to income of $1.7 million, driven by higher sales volume and better overhead coverage, despite increased patent litigation expenses.
- Kronos Equity Income: Equity in net income of Kronos swung from a loss of $9.6 million in Q1 2009 to income of $15.4 million in Q1 2010. This was due to a 29% increase in sales volume, lower manufacturing costs, and a $35.2 million non-cash income tax benefit from a favorable European Court ruling.
- Litigation Settlement: A $32.2 million litigation settlement expense was recognized in Q1 2010 related to the case Contran Corporation v. Terry S. Casey. This was partially offset by $18.2 million in insurance recoveries.
- Debt Increase: Long-term debt increased by approximately $17.4 million, primarily due to an $18.0 million promissory note issued as part of the litigation settlement mentioned above.
Guidance, Outlook, and Risks
- Outlook: Management expects CompX's demand to remain elevated as economic conditions improve, though raw material cost volatility is a concern. Kronos expects to operate at near-full capacity for the remainder of 2010 and anticipates higher average selling prices for TiO2, leading to improved operating performance for the full year.
- Liquidity: The company believes cash generated from operations and cash on hand ($25.3 million in cash and equivalents) will be sufficient to meet liquidity needs for the next 12 months. However, CompX was unable to borrow under its revolving credit facility in Q1 2010 due to a covenant restriction regarding earnings before interest and tax.
- Legal Risks: Significant ongoing litigation includes lead pigment and asbestos claims. While the company believes these actions are without merit, the resolution of any case could result in material accruals. A patent infringement case involving CompX and Humanscale is ongoing, with a jury awarding CompX over $19 million in damages (subject to appeal), though no receivable has been accrued.
- Environmental Risks: The company has accrued approximately $45 million for environmental remediation at roughly 50 sites. The upper end of the reasonably possible cost range is estimated at $80 million. Actual costs could exceed accruals due to the complexity of regulations and the solvency of other potentially responsible parties.
Investor Verification Checklist
- Litigation Settlement Terms: Verify the payment schedule and collateral requirements for the $18.0 million promissory note issued in the Contran v. Casey settlement.
- CompX Credit Facility: Monitor CompX's ability to comply with the earnings-to-interest expense covenant to ensure access to its $37.5 million revolving credit facility.
- Kronos Tax Benefit Sustainability: Assess the long-term viability of Kronos's German tax net operating loss carryforwards and the risk of future valuation allowances if economic recovery stalls.
- Environmental Accruals: Review updates on the $45 million environmental accrual and the potential for costs to exceed the $80 million upper estimate.
- Patent Litigation Outcome: Track the final judgment and potential appeals in the CompX vs. Humanscale patent infringement case regarding the $19 million jury award.